Literature DB >> 26614912

The histone deacetylase inhibitor Entinostat enhances polymer-mediated transgene expression in cancer cell lines.

Jacob J Elmer1, Matthew D Christensen1, Sutapa Barua1, Jennifer Lehrman2, Karmella A Haynes2, Kaushal Rege1.   

Abstract

Eukaryotic cells maintain an immense amount of genetic information by tightly wrapping their DNA around positively charged histones. While this strategy allows human cells to maintain more than 25,000 genes, histone binding can also block gene expression. Consequently, cells express histone acetyl transferases (HATs) to acetylate histone lysines and release DNA for transcription. Conversely, histone deacetylases (HDACs) are employed for restoring the positive charge on the histones, thereby silencing gene expression by increasing histone-DNA binding. It has previously been shown that histones bind and silence viral DNA, while hyperacetylation of histones via HDAC inhibition restores viral gene expression. In this study, we demonstrate that treatment with Entinostat, an HDAC inhibitor, enhances transgene (luciferase) expression by up to 25-fold in human prostate and murine bladder cancer cell lines when used with cationic polymers for plasmid DNA delivery. Entinostat treatment altered cell cycle progression, resulting in a significant increase in the fraction of cells present in the G0/G1 phase at low micromolar concentrations. While this moderate G0/G1 arrest disappeared at higher concentrations, a modest increase in the fraction of apoptotic cells and a decrease in cell proliferation were observed, consistent with the known anticancer effects of the drug. DNase accessibility studies revealed no significant change in plasmid transcriptional availability with Entinostat treatment. However, quantitative PCR studies indicated that Entinostat treatment, at the optimal dose for enhancing transgene expression, led to an increase in the amount of plasmid present in the nucleus in two cancer cell lines. Taken together, our results show that Entinostat enhances polymer- mediated transgene expression and can be useful in applications related to transient protein expression in mammalian cells. Biotechnol. Bioeng. 2016;113: 1345-1356.
© 2015 Wiley Periodicals, Inc. © 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  acetylation; epigenetic silencing; histones; non-viral gene delivery; transient protein expression

Mesh:

Substances:

Year:  2015        PMID: 26614912      PMCID: PMC5140276          DOI: 10.1002/bit.25898

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  52 in total

Review 1.  Histonefection: Novel and potent non-viral gene delivery.

Authors:  Mohammadi Kaouass; Raymond Beaulieu; Danuta Balicki
Journal:  J Control Release       Date:  2006-06-27       Impact factor: 9.776

2.  Role for centromeric heterochromatin and PML nuclear bodies in the cellular response to foreign DNA.

Authors:  Cleo L Bishop; Michal Ramalho; Nachiket Nadkarni; Wing May Kong; Christopher F Higgins; Nina Krauzewicz
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

Review 3.  HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention.

Authors:  X-J Yang; E Seto
Journal:  Oncogene       Date:  2007-08-13       Impact factor: 9.867

4.  Identification of novel isoform-selective inhibitors within class I histone deacetylases.

Authors:  Erding Hu; Edward Dul; Chiu-Mei Sung; Zunxuan Chen; Robert Kirkpatrick; Gui-Feng Zhang; Kyung Johanson; Ronggang Liu; Amparo Lago; Glenn Hofmann; Ricardo Macarron; Maite de los Frailes; Paloma Perez; John Krawiec; James Winkler; Michael Jaye
Journal:  J Pharmacol Exp Ther       Date:  2003-09-15       Impact factor: 4.030

5.  Histone deacetylase inhibitors induce reactivation of herpes simplex virus type 1 in a latency-associated transcript-independent manner in neuronal cells.

Authors:  Robert J Danaher; Robert J Jacob; Marion R Steiner; Will R Allen; James M Hill; Craig S Miller
Journal:  J Neurovirol       Date:  2005-07       Impact factor: 2.643

6.  The histone deacetylase inhibitor MS-275 promotes differentiation or apoptosis in human leukemia cells through a process regulated by generation of reactive oxygen species and induction of p21CIP1/WAF1 1.

Authors:  Roberto R Rosato; Jorge A Almenara; Steven Grant
Journal:  Cancer Res       Date:  2003-07-01       Impact factor: 12.701

7.  Analysis of cell cycle by flow cytometry.

Authors:  Piotr Pozarowski; Zbigniew Darzynkiewicz
Journal:  Methods Mol Biol       Date:  2004

8.  The class I HDAC inhibitor MGCD0103 induces cell cycle arrest and apoptosis in colon cancer initiating cells by upregulating Dickkopf-1 and non-canonical Wnt signaling.

Authors:  Shaheen Sikandar; Diana Dizon; Xiling Shen; Zuomei Li; Jeffery Besterman; Steven M Lipkin
Journal:  Oncotarget       Date:  2010-11

9.  Histone deacetylase 8 is required for centrosome cohesion and influenza A virus entry.

Authors:  Yohei Yamauchi; Heithem Boukari; Indranil Banerjee; Ivo F Sbalzarini; Peter Horvath; Ari Helenius
Journal:  PLoS Pathog       Date:  2011-10-27       Impact factor: 6.823

10.  Activation of silenced cytokine gene promoters by the synergistic effect of TBP-TALE and VP64-TALE activators.

Authors:  Kim Anthony; Abhijit More; Xiaoliu Zhang
Journal:  PLoS One       Date:  2014-04-22       Impact factor: 3.240

View more
  4 in total

1.  A library of aminoglycoside-derived lipopolymer nanoparticles for delivery of small molecules and nucleic acids.

Authors:  Sudhakar Godeshala; Bhavani Miryala; Subhadeep Dutta; Matthew D Christensen; Purbasha Nandi; Po-Lin Chiu; Kaushal Rege
Journal:  J Mater Chem B       Date:  2020-09-30       Impact factor: 6.331

2.  An inhibitor screen identifies histone-modifying enzymes as mediators of polymer-mediated transgene expression from plasmid DNA.

Authors:  Matthew D Christensen; Rajeshwar Nitiyanandan; Seyedehmelika Meraji; René Daer; Sudhakar Godeshala; Sheba Goklany; Karmella Haynes; Kaushal Rege
Journal:  J Control Release       Date:  2018-06-28       Impact factor: 9.776

3.  Dysregulation of Sirtuin 2 (SIRT2) and histone H3K18 acetylation pathways associates with adverse prostate cancer outcomes.

Authors:  Shivashankar Damodaran; Nathan Damaschke; Joseph Gawdzik; Bing Yang; Cedric Shi; Glenn O Allen; Wei Huang; John Denu; David Jarrard
Journal:  BMC Cancer       Date:  2017-12-20       Impact factor: 4.430

4.  Pterostilbene attenuates the proliferation and differentiation of TNF-α-treated human periodontal ligament stem cells.

Authors:  Min Yi; Guanglei Wang; Jianhua Niu; Minghui Peng; Yi Liu
Journal:  Exp Ther Med       Date:  2022-02-22       Impact factor: 2.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.